ALPHA-ORBIT-3 Trademark

Trademark Overview

On Tuesday, April 30, 2024, a trademark application was filed for ALPHA-ORBIT-3 with the United States Patent and Trademark Office. The USPTO has given the ALPHA-ORBIT-3 trademark a serial number of 98527232. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 10, 2024. This trademark is owned by Astria Therapeutics, Inc.. The ALPHA-ORBIT-3 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of allergic and inflammatory diseases and disorders
alpha-orbit-3

General Information

Serial Number98527232
Word MarkALPHA-ORBIT-3
Filing DateTuesday, April 30, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2024

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of allergic and inflammatory diseases and disorders
Pseudo MarkALPHA ORBIT THREE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 30, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstria Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameAstria Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Tuesday, April 30, 2024NEW APPLICATION ENTERED
Thursday, June 6, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 6, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 14, 2024ASSIGNED TO EXAMINER
Friday, November 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

orbit alpha diseases disorders inflammatory allergic treatment pharmaceuticals